Antonio Lara-Padron
Overview
Explore the profile of Antonio Lara-Padron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delgado-Jimenez J, Segovia-Cubero J, Almenar-Bonet L, de Juan-Baguda J, Lara-Padron A, Garcia-Pinilla J, et al.
J Clin Med
. 2022 Mar;
11(5).
PMID: 35268260
Hyperkalaemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction (HFrEF) as it limits the use of some prognostic-modifying drugs and has a...
2.
Martinez-Santos P, Velazquez-Martin M, Barbera J, Fernandez Perez C, Lopez-Meseguer M, Lopez-Reyes R, et al.
Rev Esp Cardiol (Engl Ed)
. 2020 Jul;
74(5):384-392.
PMID: 32654945
Introduction And Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) treatment has evolved in the last decade. However, there is scarce information on the long-term impact of this progress in a real-life...
3.
Kaplon-Cieslicka A, Laroche C, Crespo-Leiro M, Coats A, Anker S, Filippatos G, et al.
ESC Heart Fail
. 2020 Jul;
7(5):2098-2112.
PMID: 32618139
Aims: In hospitalized patients with a clinical diagnosis of acute heart failure (HF) with preserved ejection fraction (HFpEF), the aims of this study were (i) to assess the proportion meeting...
4.
Crespo-Leiro M, Barge-Caballero E, Segovia-Cubero J, Gonzalez-Costello J, Lopez-Fernandez S, Garcia-Pinilla J, et al.
Rev Esp Cardiol (Engl Ed)
. 2019 Nov;
73(4):313-323.
PMID: 31672562
Introduction And Objectives: Hyperkalemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction because it limits the use of effective drugs. We report...
5.
Crespo-Leiro M, Segovia-Cubero J, Gonzalez-Costello J, Bayes-Genis A, Lopez-Fernandez S, Roig E, et al.
Rev Esp Cardiol (Engl Ed)
. 2015 May;
68(9):785-93.
PMID: 26003504
Introduction And Objectives: To estimate the percentage of heart failure patients in Spain that received the European Society of Cardiology recommended treatments, and in those that did not, to determine...
6.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Gonzalez J, Caballero-Estevez N, Martin-Casanas F, et al.
Europace
. 2015 Jan;
17(4):598-602.
PMID: 25564552
Aims: Frailty status impacts the prognosis in older patients with heart disease. However, frailty status impact is unknown in patients with non-ischaemic cardiomyopathy after cardiac resynchronization therapy (CRT). Methods And...
7.
Garcia-Gonzalez M, De Mora-Martin M, Lopez-Fernandez S, Lopez-Diaz J, Martinez-Selles M, Romero-Garcia J, et al.
Cardiovasc Drugs Ther
. 2013 Jul;
27(6):573-9.
PMID: 23887741
Background: Advanced heart failure (HF) is associated with high morbidity and mortality; it represents a major burden for the health system. Episodes of acute decompensation requiring frequent and prolonged hospitalizations...
8.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Gomez M, Garcia-Baute M, Arroyo-Ucar E, Avanzas P, et al.
Crit Pathw Cardiol
. 2012 Nov;
11(4):214-7.
PMID: 23149365
Cardiopulmonary exercise testing (CPET) is used in cardiology to grade the severity of heart failure and to assess its prognosis. However, it is unknown whether CPET may be a useful...
9.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Gomez M, Garcia-Baute M, Arroyo-Ucar E, Avanzas P, et al.
Int J Cardiol
. 2012 Jan;
155(3):470-1.
PMID: 22243935
No abstract available.
10.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, Hernandez-Garcia C, Tome M, Lara-Padron A
Int J Cardiol
. 2011 Mar;
149(1):141-2.
PMID: 21371763
No abstract available.